Sequence 3 from Patent WO2012134813

Run BLAST
Find regions of similarity between this sequence and other sequences using BLAST.
Pick Primers
Design and test primers for this sequence using Primer-BLAST.

The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS. [Respir Res. 2024]
The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS.
Grigoropoulos I, Tsioulos G, Kastrissianakis A, Shapira S, Green O, Rapti V, Tsakona M, Konstantinos T, Savva A, Kavatha D, et al. Respir Res. 2024 Apr 1; 25(1):151. Epub 2024 Apr 1.
Checkpoint CD24 function on tumor and immunotherapy. [Front Immunol. 2024]
Checkpoint CD24 function on tumor and immunotherapy.
Huang S, Zhang X, Wei Y, Xiao Y. Front Immunol. 2024; 15:1367959. Epub 2024 Feb 29.
Surprising magic of CD24 beyond cancer. [Front Immunol. 2023]
Surprising magic of CD24 beyond cancer.
Wang H, Shi P, Shi X, Lv Y, Xie H, Zhao H. Front Immunol. 2023; 14:1334922. Epub 2024 Jan 19.

RefSeq alternative splicing
See 6 reference mRNA sequence splice variants for the CD24 gene.

Your browsing activity is empty.

Activity recording is turned off.

Nucleotide